Mkts

Moleculin Biotech, Inc.

NASDAQ: MBRX
$7.37+0.28 (+4.02%)
As of Oct 27, 10:04 AM ET

Key statistics

Day range
7.177.43
52-week range
3.23315.00
Today
Open7.19
Previous close7.37
Volume1.18M
Valuation
Market cap7.19M
P/E ratio—
EPS (TTM)-14.53
Income & risk
Dividend / yield—
Beta2.13
Avg volume62.9K
Discussion

MBRX News

Stories mentioning MBRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development5,3785,1183,7383,6003,4354,4554,9324,090
Sales General & Admin
Total Operating Expenses7,8747,5345,9065,7205,9436,6447,1356,185
Operating Income (Loss)(7,874)(7,534)(5,906)(5,720)(5,943)(6,644)(7,135)(6,185)
Interest Income
Interest Expense
Other Expense76.00(49.00)16.004.009.0012.009.0011.00
Pretax Income
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)(12,845)15,552(25,399)(17,809)(5,904)(6,584)(7,024)(6,015)
Earnings Per Share (Basic)(3.54)13.12(0.68)(1.15)(15.80)(47.71)(1.89)(2.37)
Earnings Per Share (Diluted)
Weighted Average Shares Outstanding (Basic)4,1241,18537,30415,526374.00138.003,7142,543
Weighted Average Shares Outstanding (Diluted)

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MBRX

Moleculin Biotech, Inc. (NASDAQ: MBRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol MBRX. It last traded at $7.37 (Oct 27, 2026, 10:04 AM ET), up 4.0% on the day. That gives Moleculin Biotech a market capitalisation of $7.2M.

Over the past 52 weeks MBRX has traded between $3.23 and $315.00.

Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $12.8M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026$0-$12.8M
Dec 31, 2025$0$15.6M
Sep 30, 2025$0-$25.4M
Jun 30, 2025$0-$17.8M

From Moleculin Biotech’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…